HDAC inhibitors dysregulate neural stem cell activity in the postnatal mouse brain

International Journal of Developmental Neuroscience

Volumn 31, Issue 6, 2013, Pages 434-447

  Foti, Stacey Beth ^a   Chou, Athena ^a   Moll, Andrew D ^a   Roskams, A Jane ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

HDAC inhibitors; Neurogenesis; Neurospheres; Valproic acid (valproate)

Indexed keywords

HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITOR; THYMIDINE DERIVATIVE; TRICHOSTATIN A; VALPROIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL SUBPOPULATION; CONTROLLED STUDY; DENTATE GYRUS; GRANULE CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEWBORN; NONHUMAN; OLFACTORY BULB; PERINATAL PERIOD; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; ROSTRAL MIGRATORY STREAM; SUBVENTRICULAR ZONE;

BRDU; BROMODEOXYURIDINE; CHLORODEOXYURIDINE; CLDU; DAYS IN VITRO; DENTATE GYRUS; DG; DIV; HDAC INHIBITORS; HDACI; HDACS; HISTONE DEACETYLASES; IDU; IODODEOXYURIDINE; NEURAL STEM CELLS; NEUROGENESIS; NEUROSPHERES; NSCS; OB; OE; OLFACTORY BULB; OLFACTORY EPITHELIUM; OLFACTORY RECEPTOR NEURON; ORN; P; POSTNATAL DAY; RMS; ROSTRAL MIGRATORY STREAM; SUBVENTRICULAR ZONE; SVZ; TRICHOSTATIN A; TSA; VALPROIC ACID; VALPROIC ACID (VALPROATE); VPA;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELL DIFFERENTIATION; CELLS, CULTURED; DEOXYCYTIDINE; DEOXYURIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; MICE; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; NEUROGENESIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SOXB1 TRANSCRIPTION FACTORS; VALPROIC ACID;

MAMMALIA; MUS;

EID: 84880039835     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2013.03.008     Document Type: Article

References (49)

1. Abel T., Zukin R.S. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Current Opinion in Pharmacology 2008, 8:57-64.
2. Akiba Y., Cave J.W., Akiba N., Langley B., Ratan R.R., Baker H. Histone deacetylase inhibitors de-repress tyrosine hydroxylase expression in the olfactory bulb and rostral migratory stream. Biochemical and Biophysical Research Communications 2010, 393:673-677.
3. Aldenkamp A., Vigevano F., Arzimanoglou A., Covanis A. Role of valproate across the ages. Treatment of epilepsy in children. Acta Neurologica Scandinavica: Supplementum 2006, 184:1-13.
4. Aten J.A., Bakker P.J., Stap J., Boschman G.A., Veenhof C.H. DNA double labelling with IdUrd and CldUrd for spatial and temporal analysis of cell proliferation and DNA replication. Histochemical Journal 1992, 24:251-259.
5. Balasubramaniyan V., Boddeke E., Bakels R., Kust B., Kooistra S., Veneman A., Copray S. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. Neuroscience 2006, 143:939-951.
6. Bieliauskas A.V., Pflum M.K. Isoform-selective histone deacetylase inhibitors. Chemical Society Reviews 2008, 37:1402-1413.
7. Cayre M., Canoll P., Goldman J.E. Cell migration in the normal and pathological postnatal mammalian brain. Progress in Neurobiology 2009, 88:41-63.
8. Cecchi G.A., Petreanu L.T., Alvarez-Buylla A., Magnasco M.O. Unsupervised learning and adaptation in a model of adult neurogenesis. Journal of Computational Neuroscience 2001, 11:175-182.
9. Day J.J., Sweatt J.D. Epigenetic mechanisms in cognition. Neuron 2011, 70:813-829.
10. des Portes V., Pinard J.M., Billuart P., Vinet M.C., Koulakoff A., Carrie A., Gelot A., Dupuis E., Motte J., Berwald-Netter Y., Catala M., Kahn A., Beldjord C., Chelly J. A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar heterotopia and lissencephaly syndrome. Cell 1998, 92:51-61.
11. DeVane C.L. Pharmacokinetics, drug interactions, and tolerability of valproate. Psychopharmacology Bulletin 2003, 37(Suppl. 2):25-42.
12. DiLiberti J.H., Farndon P.A., Dennis N.R., Curry C.J. The fetal valproate syndrome. American Journal of Medical Genetics 1984, 19:473-481.
13. Dovey O.M., Foster C.T., Cowley S.M. Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:8242-8247.
14. Duan W., Ladenheim B., Cutler R.G., Kruman I.I., Cadet J.L., Mattson M.P. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. Journal of Neurochemistry 2002, 80:101-110.
15. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. Journal of Neuroscience 2003, 23:7311-7316.
16. Finlay B.L., Darlington R.B. Linked regularities in the development and evolution of mammalian brains. Science 1995, 268:1578-1584.
17. Georgieff M.K. Nutrition and the developing brain: nutrient priorities and measurement. American Journal of Clinical Nutrition 2007, 85:614S-620S.
18. Gheusi G., Cremer H., McLean H., Chazal G., Vincent J.D., Lledo P.M. Importance of newly generated neurons in the adult olfactory bulb for odor discrimination. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:1823-1828.
19. Giordano M., Danova M., Pellicciari C., Wilson G.D., Mazzini G., Conti A.M., Franchini G., Riccardi A., Romanini M.G. Proliferating cell nuclear antigen (PCNA)/cyclin expression during the cell cycle in normal and leukemic cells. Leukemia Research 1991, 15:965-974.
20. Hao Y., Creson T., Zhang L., Li P., Du F., Yuan P., Gould T.D., Manji H.K., Chen G. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. Journal of Neuroscience 2004, 24:6590-6599.
21. Hsieh J., Gage F.H. Epigenetic control of neural stem cell fate. Current Opinion in Genetics and Development 2004, 14:461-469.
22. Humphrey G.W., Wang Y.H., Hirai T., Padmanabhan R., Panchision D.M., Newell L.F., McKay R.D., Howard B.H. Complementary roles for histone deacetylases 1, 2, and 3 in differentiation of pluripotent stem cells. Differentiation 2008, 76:348-356.
23. Jung G.A., Yoon J.Y., Moon B.S., Yang D.H., Kim H.Y., Lee S.H., Bryja V., Arenas E., Choi K.Y. Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway. BMC Cell Biology 2008, 9:66.
24. Kataoka S., Takuma K., Hara Y., Maeda Y., Ago Y., Matsuda T. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. International Journal of Neuropsychopharmacology 2011, 1-13.
25. Kruman I.I., Kumaravel T.S., Lohani A., Pedersen W.A., Cutler R.G., Kruman Y., Haughey N., Lee J., Evans M., Mattson M.P. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. Journal of Neuroscience 2002, 22:1752-1762.
26. Lagger G., O'Carroll D., Rembold M., Khier H., Tischler J., Weitzer G., Schuettengruber B., Hauser C., Brunmeir R., Jenuwein T., Seiser C. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO Journal 2002, 21:2672-2681.
27. Lillycrop K.A., Slater-Jefferies J.L., Hanson M.A., Godfrey K.M., Jackson A.A., Burdge G.C. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. British Journal of Nutrition 2007, 97:1064-1073.
28. MacDonald J.L., Gin C.S., Roskams A.J. Stage-specific induction of DNA methyltransferases in olfactory receptor neuron development. Developmental Biology 2005, 288:461-473.
29. MacDonald J.L., Roskams A.J. Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development. Developmental Dynamics 2008, 237:2256-2267.
30. Macdonald J.L., Verster A., Berndt A., Roskams A.J. MBD2 and MeCP2 regulate distinct transitions in the stage-specific differentiation of olfactory receptor neurons. Molecular and Cellular Neurosciences 2010, 44:55-67.
31. Marin-Husstege M., Muggironi M., Liu A., Casaccia-Bonnefil P. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. Journal of Neuroscience 2002, 22:10333-10345.
32. Montgomery R.L., Hsieh J., Barbosa A.C., Richardson J.A., Olson E.N. Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:7876-7881.
33. Nau H., Hauck R.S., Ehlers K. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Pharmacology and Toxicology 1991, 69:310-321.
34. Rafalski V.A., Brunet A. Energy metabolism in adult neural stem cell fate. Progress in Neurobiology 2011, 93:182-203.
35. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.
36. Rosenzweig I., Vukadinovic Z., Turner A.J., Catani M. Neuroconnectivity and valproic acid: the myelin hypothesis. Neuroscience and Biobehavioral Reviews 2012, 36:1848-1856.
37. Roth T.L., Sweatt J.D. Annual Research Review: epigenetic mechanisms and environmental shaping of the brain during sensitive periods of development. Journal of Child Psychology and Psychiatry and Allied Disciplines 2011, 52:398-408.
38. Schneider J.W., Gao Z., Li S., Farooqi M., Tang T.S., Bezprozvanny I., Frantz D.E., Hsieh J. Small-molecule activation of neuronal cell fate. Nature Chemical Biology 2008, 4:408-410.
39. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine 2002, 346:476-483.
40. Shaked M., Weissmuller K., Svoboda H., Hortschansky P., Nishino N., Wolfl S., Tucker K.L. Histone deacetylases control neurogenesis in embryonic brain by inhibition of BMP2/4 signaling. PLoS ONE 2008, 3:e2668.
41. Shea T.B., Lyons-Weiler J., Rogers E. Homocysteine, folate deprivation and Alzheimer neuropathology. Journal of Alzheimer's Disease 2002, 4:261-267.
42. Shen S., Casaccia-Bonnefil P. Post-translational modifications of nucleosomal histones in oligodendrocyte lineage cells in development and disease. Journal of Molecular Neuroscience 2008, 35:13-22.
43. Shen S., Li J., Casaccia-Bonnefil P. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. Journal of Cell Biology 2005, 169:577-589.
44. Siebzehnrubl F.A., Buslei R., Eyupoglu I.Y., Seufert S., Hahnen E., Blumcke I. Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells. Experimental Brain Research 2007, 176:672-678.
45. Stangl D., Thuret S. Impact of diet on adult hippocampal neurogenesis. Genes & Nutrition 2009, 4:271-282.
46. Vega C.J., Peterson D.A. Stem cell proliferative history in tissue revealed by temporal halogenated thymidine analog discrimination. Nature Methods 2005, 2:167-169.
47. Ye F., Chen Y., Hoang T., Montgomery R.L., Zhao X.H., Bu H., Hu T., Taketo M.M., van Es J.H., Clevers H., Hsieh J., Bassel-Duby R., Olson E.N., Lu Q.R. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nature Neuroscience 2009, 12:829-838.
48. Yu I.T., Park J.Y., Kim S.H., Lee J.S., Kim Y.S., Son H. Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology 2009, 56:473-480.
49. Zhou Q., Dalgard C.L., Wynder C., Doughty M.L. Valproic acid inhibits neurosphere formation by adult subventricular cells by a lithium-sensitive mechanism. Neuroscience Letters 2011, 500:202-206.